You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Mass. Movers

Insulet narrows loss in fourth quarter

An earlier version of Insulet’s OmniPod insulin pump.

An earlier version of Insulet’s OmniPod insulin pump.

Continue reading below

Bedford’s Insulet Corp. said fourth-quarter 2013 revenue rose 19 percent to $68.5 million, compared to $57.8 million in the same period in 2012. Insulet said the revenue bump was a result of continued strong patient adoption of the OmniPod insulin pump in the United States and international markets. The company said its net loss was $2.5 million, or 4 cents per share, compared to a loss of $10.2 million, or 21 cents, in 2012. The results, however, beats analysts’ estimated loss of 9 cents.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week